SE0002738D0 - Electric actuator - Google Patents

Electric actuator

Info

Publication number
SE0002738D0
SE0002738D0 SE0002738A SE0002738A SE0002738D0 SE 0002738 D0 SE0002738 D0 SE 0002738D0 SE 0002738 A SE0002738 A SE 0002738A SE 0002738 A SE0002738 A SE 0002738A SE 0002738 D0 SE0002738 D0 SE 0002738D0
Authority
SE
Sweden
Prior art keywords
proteins
peptides
homology
seq
subsequence
Prior art date
Application number
SE0002738A
Other languages
Swedish (sv)
Inventor
Lennart Stridsberg
Original Assignee
Stridsberg Innovation Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of SE0002738D0 publication Critical patent/SE0002738D0/en
Application filed by Stridsberg Innovation Ab filed Critical Stridsberg Innovation Ab
Priority to SE0002738A priority Critical patent/SE0002738D0/en
Priority to PCT/EP2001/008409 priority patent/WO2002008426A2/en
Priority to AU2001287645A priority patent/AU2001287645A1/en
Priority to US10/333,120 priority patent/US20040091495A1/en
Priority to ZA200300014A priority patent/ZA200300014B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

The present invention provides proteins and peptides derived from Streptococcus pneuminiae, type 3, which all the complement factor H (fH). These proteins and peptides show a homology of at least 50%, preferably at least 60%, and most preferably at least 70% with the subsequence from Thr38 to Lys 149 of the sequence disclosed herein as SEQ ID NO: 1. The above subsequence, which is located in the amino-terminal of a surface protein isolated from Streptococcus Pneuminiae, type 3, is highly associated with binding of fH. In another aspect, the invention relates to proteins and peptides showing a homology of at least 85%, preferably at least 95%, and most preferably at least 99% with the Hic protein, the amino acid sequence of which is disclosed is SEQ ID NO: 1. The invention also provides vaccine compositions comprising the above proteins and peptides.
SE0002738A 2000-07-20 2000-07-20 Electric actuator SE0002738D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0002738A SE0002738D0 (en) 2000-07-20 2000-07-20 Electric actuator
PCT/EP2001/008409 WO2002008426A2 (en) 2000-07-20 2001-07-19 Fh-binding protein of streptococcus pneumoniae
AU2001287645A AU2001287645A1 (en) 2000-07-20 2001-07-19 Fh-binding protein of streptococcus pneumiae
US10/333,120 US20040091495A1 (en) 2000-07-20 2001-07-19 Protein
ZA200300014A ZA200300014B (en) 2000-07-20 2003-01-02 Protein.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0002738A SE0002738D0 (en) 2000-07-20 2000-07-20 Electric actuator

Publications (1)

Publication Number Publication Date
SE0002738D0 true SE0002738D0 (en) 2000-07-19

Family

ID=20280563

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0002738A SE0002738D0 (en) 2000-07-20 2000-07-20 Electric actuator

Country Status (2)

Country Link
SE (1) SE0002738D0 (en)
ZA (1) ZA200300014B (en)

Also Published As

Publication number Publication date
ZA200300014B (en) 2004-03-10

Similar Documents

Publication Publication Date Title
WO2002008426A3 (en) Fh-binding protein of streptococcus pneumoniae
DE60035419D1 (en) ANTIGENIC PEPTIDES FROM NEISSERIA
ATE368053T1 (en) ANTIMICROBIAL PEPTIDES
ATE382055T1 (en) WNT-1 RELATED POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THEREOF
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
DE60039050D1 (en) ANTIGENIC MENINGOCOCKS PEPTIDES
WO1998004702A3 (en) Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use
DE69827262D1 (en) PENAEIDINE: ANTIMICROBIAL PEPTIDES FROM CARBURATORS
ATE282634T1 (en) CHAPERONINE 10
DE69935599D1 (en) MODIFIED HCV PEPTIDE VACCINES
SE8801723D0 (en) FIBRONECTIN BINDING PROTEIN AS WELL AS IT'S PREPARATION
SE0002738D0 (en) Electric actuator
SE0002728D0 (en) New compound
ATE218064T1 (en) IMMUNOGENIC TLP COMPOSITION
NO20011263L (en) Moraxella Catarrhalis BASBO34 polypeptides and uses thereof
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
WO2001098355A3 (en) Cgi-69 compositions and methods of use
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
JP2004500829A5 (en)
WO2001060972A3 (en) Novel peptides and methods of use
PT959895E (en) PEPTIDES THAT RESIST ANTIBODIES AGAINST A CONSENSUS PEOPLE OF THE CS4-CFA / I PROTEIN FAMILY
WO2002026978A1 (en) Novel proteins, genes encoding them and method of using the same
WO2004069989A3 (en) Novel purified phosphodiesterase polypeptides
KR960034414A (en) A novel SWI3 gene (SRG3) isolated from a mouse and a protein expressed therefrom
WO2000026240A3 (en) Streptococcal alpha2m-binding protein